Literature DB >> 19870496

THE INCIDENCE OF NEUTRALIZING ANTIBODIES FOR SWINE INFLUENZA VIRUS IN THE SERA OF HUMAN BEINGS OF DIFFERENT AGES.

R E Shope1.   

Abstract

Sera from a very high proportion of the human adults and new-born infants studied neutralized swine influenza virus; sera from children below the age of 12 years seldom exerted such an effect. The results of neutralization experiments with human sera and the virus of swine influenza have been compared with the outcome of similar tests with the virus of human influenza, and it seems evident that the presence of antibodies neutralizing swine influenza virus cannot be deemed the result of repeated exposures to the current human type of virus. From the known history of swine influenza and the similarity of its etiologic virus to that obtained from man it seems likely that the virus of swine influenza is the surviving prototype of the agent primarily responsible for the great human pandemic of 1918, as Laidlaw has already suggested. The presence in human sera of antibodies neutralizing swine influenza virus is believed to indicate a previous immunizing exposure to, or infection with, an influenza virus of the 1918 type.

Entities:  

Year:  1936        PMID: 19870496      PMCID: PMC2133359          DOI: 10.1084/jem.63.5.669

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.

Authors:  T Francis
Journal:  Science       Date:  1934-11-16       Impact factor: 47.728

2.  SWINE INFLUENZA : III. FILTRATION EXPERIMENTS AND ETIOLOGY.

Authors:  R E Shope
Journal:  J Exp Med       Date:  1931-07-31       Impact factor: 14.307

3.  THE INFECTION OF FERRETS WITH SWINE INFLUENZA VIRUS.

Authors:  R E Shope
Journal:  J Exp Med       Date:  1934-06-30       Impact factor: 14.307

4.  THE INFECTION OF MICE WITH SWINE INFLUENZA VIRUS.

Authors:  R E Shope
Journal:  J Exp Med       Date:  1935-09-30       Impact factor: 14.307

5.  NEUTRALIZATION TESTS WITH SERA OF CONVALESCENT OR IMMUNIZED ANIMALS AND THE VIRUSES OF SWINE AND HUMAN INFLUENZA.

Authors:  T Francis; R E Shope
Journal:  J Exp Med       Date:  1936-04-30       Impact factor: 14.307

6.  IMMUNOLOGICAL STUDIES WITH THE VIRUS OF INFLUENZA.

Authors:  T Francis; T P Magill
Journal:  J Exp Med       Date:  1935-09-30       Impact factor: 14.307

7.  THE INCIDENCE OF NEUTRALIZING ANTIBODIES FOR HUMAN INFLUENZA VIRUS IN THE SERUM OF HUMAN INDIVIDUALS OF DIFFERENT AGES.

Authors:  T Francis; T P Magill
Journal:  J Exp Med       Date:  1936-04-30       Impact factor: 14.307

  7 in total
  47 in total

1.  The new influenza A H1N1 virus: balancing on the interface of humans and animals.

Authors:  Frank J U M van der Meer; Karin Orsel; Herman W Barkema
Journal:  Can Vet J       Date:  2010-01       Impact factor: 1.008

2.  Characterization of the 1918 "Spanish" influenza virus neuraminidase gene.

Authors:  A H Reid; T G Fanning; T A Janczewski; J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  1918 Spanish influenza: the secrets remain elusive.

Authors:  R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

4.  Antigenic memory to influenza A viruses in man determined by monovalent vaccines.

Authors:  W M Marine; J E Thomas
Journal:  Postgrad Med J       Date:  1979-02       Impact factor: 2.401

5.  Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene.

Authors:  A H Reid; T G Fanning; J V Hultin; J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 6.  2009 H1N1 influenza.

Authors:  Seth J Sullivan; Robert M Jacobson; Walter R Dowdle; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2009-12-10       Impact factor: 7.616

7.  Characterization of a 1980-swine recombinant influenza virus possessing H1 hemagglutinin and N2 neuraminidase similar to that of the earliest Hong Kong (H3N2) virus.

Authors:  K Nerome; Y Yoshioka; S Sakamoto; H Yasuhara; A Oya
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza.

Authors:  Ted Ross; Shanta Zimmer; Don Burke; Corey Crevar; Donald Carter; James Stark; Brendan Giles; Richard Zimmerman; Stephen Ostroff; Bruce Lee
Journal:  PLoS Curr       Date:  2010-02-24

9.  Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.

Authors:  Shanta M Zimmer; Corey J Crevar; Donald M Carter; James H Stark; Brendan M Giles; Richard K Zimmerman; Stephen M Ostroff; Bruce Y Lee; Donald S Burke; Ted M Ross
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

Review 10.  An influenza A H1N1 virus revival - pandemic H1N1/09 virus.

Authors:  M Michaelis; H W Doerr; J Cinatl
Journal:  Infection       Date:  2009-09-18       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.